SevenBridge Financial »

Crispr Therapeutics shares owned by SevenBridge Financial

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by SevenBridge Financial from 13F filings

Historical chart of SevenBridge Financial investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by SevenBridge Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by SevenBridge Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $316k 5.7k 55.89
2023-12-31 $393k 6.3k 62.60
2023-09-30 $285k 6.3k 45.39
2023-06-30 $352k 6.3k 56.14
2023-03-31 $279k 6.2k 45.23
2022-12-31 $256k 6.3k 40.65
2022-09-30 $377k 5.8k 65.27
2022-06-30 $351k 5.8k 60.77
2022-03-31 $312k 5.0k 62.79
2021-12-31 $379k 5.0k 75.82
2021-09-30 $626k 5.6k 111.95
2021-06-30 $905k 5.6k 161.84
2021-03-31 $667k 5.5k 121.83
2020-12-31 $838k 5.5k 153.06